Sri Sai Subramanyam Challa. “EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES”. Journal of Population Therapeutics and Clinical Pharmacology 28, no. 2 (August 25, 2021): 436–448. Accessed October 10, 2025. https://jptcp.com/index.php/jptcp/article/view/7421.